Nemec Sarah — SEC Form 4 filings
SEC reporting owner CIK 2023538. 5 Form 4 filings on record with FilingPulse; latest filed 2026-02-04.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2024-07-24 to 2026-02-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 3 filings — 5,250 shares, $4,097 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
- Largest priced transaction: purchase of 2,500 shares @ $0.64 ($1,594) in Bolt Biotherapeutics, Inc., filed 2025-05-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | Senior VP, Finance and PAO | 5 | 4 legs · 5,250 sh · $4,097 | — | 23 |
Form 4 filings — Nemec Sarah
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-04 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Purchase (P): 125 @ $4.61 · Grant/award (A): 8,000 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Grant/award (A): 1,236 (derivative) · Disposition to issuer (D): 1,236 (derivative) · Grant/award (A): 375 (derivative) · Disposition to issuer (D): 375 (derivative) · Grant/award (A): 600 (derivative) · Disposition to issuer (D): 600 (derivative) · +12 more | EDGAR |
| 2025-10-24 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Purchase (P): 125 @ $5.49 · Grant/award (A): 23,000 @ $0 | EDGAR |
| 2025-05-05 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Purchase (P): 2,500 @ $0.50 · Purchase (P): 2,500 @ $0.64 · Grant/award (A): 226,000 (derivative) @ $0 | EDGAR |
| 2024-07-24 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Grant/award (A): 50,000 (derivative) @ $0 · Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2023538 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →